How Fear of COVID-19 Can Affect Treatment Choices for Anaplastic Large Cell Lymphomas ALK+ Therapy: A Case Report

Background: The t (2; 5) chromosomal rearrangement of the ALK gene with nucleophosmin 1 gene (NPM1), resulting in an NPM1–ALK fusion, was first demonstrated in 1994 in anaplastic large cell lymphoma, (ALCL), a T-cell lymphoma responsive to cyclophosphamide, abriblastine, vincristine and prednisone i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Healthcare (Basel)
Autors principals: Sica, Antonello, Sagnelli, Caterina, Casale, Beniamino, Svanera, Gino, Creta, Massimiliano, Calogero, Armando, Franco, Renato, Sagnelli, Evangelista, Ronchi, Andrea
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7912420/
https://ncbi.nlm.nih.gov/pubmed/33572634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/healthcare9020135
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars